However, clinical evidence suggests that baseline functions of glucose transport and insulin resistance are the main determinants of the impact of GLP-1 analog on glucose transport and glucose uptake in cardiomyocytes during hyperglycemic states in patients with T2DM [108] and during normo- or hypoglycemia in healthy subjects [109]. This evidence concerns the gene GCG and type 2 diabetes mellitus.